Dr. Steven Dow | Using Repurposed Drugs Against Cancer

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Steve Dow, professor of immunology at Colorado State University and Director of the Center for Immune and Regenerative Medicine. Dr. Dow shares insights from his groundbreaking work on myeloid-targeted immunotherapies and the innovative use of repurposed, FDA-approved drugs like losartan, palladia, and propranolol in treating canine cancers such as osteosarcoma and brain tumors. He also discusses the development of tumor vaccines, promising adjuvant trial results, and the critical role dogs play as translational models in advancing human cancer therapies. The episode highlights the future potential of bispecific antibodies and CAR-T cell therapies in both veterinary and human oncology. 📝Transcripts are available at https://www.imprimedicine.com/podcast. To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp Music Credit: Hazy by Beat Mekanik